SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-128616
Filing Date
2023-05-01
Accepted
2023-05-01 06:08:29
Documents
18
Period of Report
2023-04-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d440511d8k.htm   iXBRL 8-K 26143
2 EX-99.1 d440511dex991.htm EX-99.1 28969
6 GRAPHIC g440511g01a01.jpg GRAPHIC 55760
7 GRAPHIC g440511g0501011844649.jpg GRAPHIC 2285
8 GRAPHIC g440511g0501011844851.jpg GRAPHIC 9648
9 GRAPHIC g440511g0501011844980.jpg GRAPHIC 9493
10 GRAPHIC g440511g0501011845099.jpg GRAPHIC 7624
  Complete submission text file 0001193125-23-128616.txt   300064

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plrx-20230430.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20230430_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20230430_pre.xml EX-101.PRE 10805
12 EXTRACTED XBRL INSTANCE DOCUMENT d440511d8k_htm.xml XML 3245
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 23869751
SIC: 2834 Pharmaceutical Preparations